about
A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditionsOxidative stress associated with neuronal apoptosis in experimental models of epilepsyMitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's DiseasesOxidative stress in Alzheimer's and Parkinson's diseases: insights from the yeast Saccharomyces cerevisiaeXanthoceraside ameliorates mitochondrial dysfunction contributing to the improvement of learning and memory impairment in mice with intracerebroventricular injection of aβ1-42.Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases.Early deficits in synaptic mitochondria in an Alzheimer's disease mouse modelThe toxicity of tau in Alzheimer disease: turnover, targets and potential therapeuticsIdentification of human presequence protease (hPreP) agonists for the treatment of Alzheimer's disease.Oxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunctionHow the Wnt signaling pathway protects from neurodegeneration: the mitochondrial scenarioNew insights in the amyloid-Beta interaction with mitochondriaGeniposide Alleviates Amyloid-Induced Synaptic Injury by Protecting Axonal Mitochondrial Trafficking.Mitochondrial dynamics changes with age in an APPsw/PS1dE9 mouse model of Alzheimer's disease.Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cellMitochondrial dysfunction and Down's syndrome: is there a role for coenzyme Q(10) ?Mechanisms of action of brain insulin against neurodegenerative diseases.Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.Chlorogenic acid protects against aluminium-induced cytotoxicity through chelation and antioxidant actions in primary hippocampal neuronal cells.Neuroprotective effect of α-mangostin on mitochondrial dysfunction and α-synuclein aggregation in rotenone-induced model of Parkinson's disease in differentiated SH-SY5Y cells.Isolation and quantification of major chlorogenic acids in three major instant coffee brands and their potential effects on H2O2-induced mitochondrial membrane depolarization and apoptosis in PC-12 cells.Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease.Mitochondrial Molecular Abnormalities Revealed by Proteomic Analysis of Hippocampal Organelles of Mice Triple Transgenic for Alzheimer Disease.Neuroprotective effects of Lycium chinense Miller against rotenone-induced neurotoxicity in PC12 cells.
P2860
Q26781560-3A19ED4B-823B-43F4-8242-21350BEF7065Q26823122-C8D70DF7-5455-490D-A111-5EE231621E58Q26859141-C9A203B3-8F16-45FB-8CC8-5733A14982FDQ27692067-0B119574-FD3B-4C06-AFAD-1D5FCC2F9D3AQ33757597-FE7CADA0-3A49-4E9B-8D29-BE0A20F6B2DAQ34243986-491AEA95-22C5-436F-BEEB-9BC5FE05AF09Q34276376-76FCF90E-0CD0-49F4-96AA-40150424D374Q35216140-33C0F848-9C2E-4FAF-B862-365EE60CA48BQ35240665-7AFDA32F-737E-4AC8-8720-BEC539EDA19EQ35358475-B634C1BA-A28E-48F3-8A05-9B3E696CAF58Q35569964-FDA8A2BF-3444-4BBD-BFA8-09A2353B1988Q35864854-6E72B242-E9A3-487C-846A-28C1BDFFFCBFQ37604073-6F44C413-A0A2-4924-A9B8-CA0B06E9E938Q37659147-1BD2799F-C62E-4DFE-A255-3132DA3E141EQ37709664-A4AFD66E-CFAB-41CC-A852-CEAA444CFE08Q37947197-9CBFEFCD-88BC-4B78-BB44-2C0EEC906F0DQ38176522-E17520E9-875C-4698-AC3E-BE148C3970C6Q38962796-C5FB7671-E13F-4342-8CB3-0C626DC5505DQ46330733-4983C60A-7370-4160-A6DE-5572AA6CC19AQ46337717-1483BF00-16AC-4B34-8139-FFC215FA3ECFQ46991155-3ABE449C-B198-4B65-946C-07291955D666Q49940144-B56E80B3-6D5D-49F5-9627-A718BBC96134Q53396803-DB19F206-3307-445A-8C6F-FE35BC8AF62BQ54603244-DC8B11FC-71B7-486C-8928-0CD541DE1085
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mitochondrial medicine for neurodegenerative diseases.
@en
Mitochondrial medicine for neurodegenerative diseases.
@nl
type
label
Mitochondrial medicine for neurodegenerative diseases.
@en
Mitochondrial medicine for neurodegenerative diseases.
@nl
prefLabel
Mitochondrial medicine for neurodegenerative diseases.
@en
Mitochondrial medicine for neurodegenerative diseases.
@nl
P2860
P1476
Mitochondrial medicine for neurodegenerative diseases.
@en
P2093
Shirley ShiDu Yan
P2860
P304
P356
10.1016/J.BIOCEL.2010.01.004
P577
2010-01-11T00:00:00Z